Esmolol prevents and suppresses arrhythmias during halothane anaesthesia in dogs

Ivan Dimich, Rohini Lingham, Jolie Narang, Ian Sampson, Howard Shiang

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The antiarrhythmic effect of esmolol, a selective beta1 adrenoreceptor blocker, was evaluated in the presence of epinephrine induced arrhythmias in dogs (n = 6). The arrhythmogenic dose of epinephrine (ADE) during 1.2 MAC halothane in dogs was increased from 3.23 ± 0.25 (mean ± SD) to 30.90 ± 3.56 μg · kg-1 · min-1 (P < 0.001) by the prior administration of esmolol 0.5 μg · kg-1 bolus followed by an infusion at the rate of 150 μg · kg-1 · min-1. Higher esmolol infusion doses of 200 μg · kg-1 · min-1 further increased ADE to 99.0 ± 2.92 μg · kg-1 · min-1 (P < 0.001). After discontinuation of esmolol and during continued halothane anaesthesia, ventricular tachycardia was induced by increasing the infusion rate of the 100 μg · ml-1 solution of epinephrine. In all dogs ventricular tachycardia was restored to sinus rhythm by a bolus dose of esmolol (1 μg · kg-1). We conclude that esmolol pretreatment increases the ADE during halothane anaesthesia in dogs. Our data suggest that esmolol may be useful as an antiarrhythmic agent in the management of epinephrinerelated ventricular arrhythmias during anaesthesia in man.

Original languageEnglish (US)
Pages (from-to)83-86
Number of pages4
JournalCanadian Journal of Anaesthesia
Volume39
Issue number1
DOIs
StatePublished - Jan 1992
Externally publishedYes

Fingerprint

Halothane
Cardiac Arrhythmias
Anesthesia
Dogs
Epinephrine
Ventricular Tachycardia
esmolol

Keywords

  • Anaesthetics, Volatile: halothane
  • Complications: arrhythmias
  • Sympathetic Nervous System: pharmacology, epinephrine, esmolol

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Esmolol prevents and suppresses arrhythmias during halothane anaesthesia in dogs. / Dimich, Ivan; Lingham, Rohini; Narang, Jolie; Sampson, Ian; Shiang, Howard.

In: Canadian Journal of Anaesthesia, Vol. 39, No. 1, 01.1992, p. 83-86.

Research output: Contribution to journalArticle

Dimich, Ivan ; Lingham, Rohini ; Narang, Jolie ; Sampson, Ian ; Shiang, Howard. / Esmolol prevents and suppresses arrhythmias during halothane anaesthesia in dogs. In: Canadian Journal of Anaesthesia. 1992 ; Vol. 39, No. 1. pp. 83-86.
@article{6de805a926c741c1ad1565ed5a370696,
title = "Esmolol prevents and suppresses arrhythmias during halothane anaesthesia in dogs",
abstract = "The antiarrhythmic effect of esmolol, a selective beta1 adrenoreceptor blocker, was evaluated in the presence of epinephrine induced arrhythmias in dogs (n = 6). The arrhythmogenic dose of epinephrine (ADE) during 1.2 MAC halothane in dogs was increased from 3.23 ± 0.25 (mean ± SD) to 30.90 ± 3.56 μg · kg-1 · min-1 (P < 0.001) by the prior administration of esmolol 0.5 μg · kg-1 bolus followed by an infusion at the rate of 150 μg · kg-1 · min-1. Higher esmolol infusion doses of 200 μg · kg-1 · min-1 further increased ADE to 99.0 ± 2.92 μg · kg-1 · min-1 (P < 0.001). After discontinuation of esmolol and during continued halothane anaesthesia, ventricular tachycardia was induced by increasing the infusion rate of the 100 μg · ml-1 solution of epinephrine. In all dogs ventricular tachycardia was restored to sinus rhythm by a bolus dose of esmolol (1 μg · kg-1). We conclude that esmolol pretreatment increases the ADE during halothane anaesthesia in dogs. Our data suggest that esmolol may be useful as an antiarrhythmic agent in the management of epinephrinerelated ventricular arrhythmias during anaesthesia in man.",
keywords = "Anaesthetics, Volatile: halothane, Complications: arrhythmias, Sympathetic Nervous System: pharmacology, epinephrine, esmolol",
author = "Ivan Dimich and Rohini Lingham and Jolie Narang and Ian Sampson and Howard Shiang",
year = "1992",
month = "1",
doi = "10.1007/BF03008680",
language = "English (US)",
volume = "39",
pages = "83--86",
journal = "Canadian Anaesthetists Society Journal",
issn = "0832-610X",
publisher = "Canadian Anaesthetists Society",
number = "1",

}

TY - JOUR

T1 - Esmolol prevents and suppresses arrhythmias during halothane anaesthesia in dogs

AU - Dimich, Ivan

AU - Lingham, Rohini

AU - Narang, Jolie

AU - Sampson, Ian

AU - Shiang, Howard

PY - 1992/1

Y1 - 1992/1

N2 - The antiarrhythmic effect of esmolol, a selective beta1 adrenoreceptor blocker, was evaluated in the presence of epinephrine induced arrhythmias in dogs (n = 6). The arrhythmogenic dose of epinephrine (ADE) during 1.2 MAC halothane in dogs was increased from 3.23 ± 0.25 (mean ± SD) to 30.90 ± 3.56 μg · kg-1 · min-1 (P < 0.001) by the prior administration of esmolol 0.5 μg · kg-1 bolus followed by an infusion at the rate of 150 μg · kg-1 · min-1. Higher esmolol infusion doses of 200 μg · kg-1 · min-1 further increased ADE to 99.0 ± 2.92 μg · kg-1 · min-1 (P < 0.001). After discontinuation of esmolol and during continued halothane anaesthesia, ventricular tachycardia was induced by increasing the infusion rate of the 100 μg · ml-1 solution of epinephrine. In all dogs ventricular tachycardia was restored to sinus rhythm by a bolus dose of esmolol (1 μg · kg-1). We conclude that esmolol pretreatment increases the ADE during halothane anaesthesia in dogs. Our data suggest that esmolol may be useful as an antiarrhythmic agent in the management of epinephrinerelated ventricular arrhythmias during anaesthesia in man.

AB - The antiarrhythmic effect of esmolol, a selective beta1 adrenoreceptor blocker, was evaluated in the presence of epinephrine induced arrhythmias in dogs (n = 6). The arrhythmogenic dose of epinephrine (ADE) during 1.2 MAC halothane in dogs was increased from 3.23 ± 0.25 (mean ± SD) to 30.90 ± 3.56 μg · kg-1 · min-1 (P < 0.001) by the prior administration of esmolol 0.5 μg · kg-1 bolus followed by an infusion at the rate of 150 μg · kg-1 · min-1. Higher esmolol infusion doses of 200 μg · kg-1 · min-1 further increased ADE to 99.0 ± 2.92 μg · kg-1 · min-1 (P < 0.001). After discontinuation of esmolol and during continued halothane anaesthesia, ventricular tachycardia was induced by increasing the infusion rate of the 100 μg · ml-1 solution of epinephrine. In all dogs ventricular tachycardia was restored to sinus rhythm by a bolus dose of esmolol (1 μg · kg-1). We conclude that esmolol pretreatment increases the ADE during halothane anaesthesia in dogs. Our data suggest that esmolol may be useful as an antiarrhythmic agent in the management of epinephrinerelated ventricular arrhythmias during anaesthesia in man.

KW - Anaesthetics, Volatile: halothane

KW - Complications: arrhythmias

KW - Sympathetic Nervous System: pharmacology, epinephrine, esmolol

UR - http://www.scopus.com/inward/record.url?scp=0026565753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026565753&partnerID=8YFLogxK

U2 - 10.1007/BF03008680

DO - 10.1007/BF03008680

M3 - Article

VL - 39

SP - 83

EP - 86

JO - Canadian Anaesthetists Society Journal

JF - Canadian Anaesthetists Society Journal

SN - 0832-610X

IS - 1

ER -